These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21240469)

  • 1. Courage for simplification and imperfection in the 21st century assessment of "Endocrine disruption".
    Dietrich DR
    ALTEX; 2010; 27(4):264-78. PubMed ID: 21240469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
    Chahoud I; Grote K
    Toxicology; 2016 Jul; 363-364():46-7. PubMed ID: 27430607
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro metabolism and bioavailability tests for endocrine active substances: what is needed next for regulatory purposes?
    Jacobs MN; Laws SC; Willett K; Schmieder P; Odum J; Bovee TF
    ALTEX; 2013; 30(3):331-51. PubMed ID: 23861078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.
    Coady KK; Biever RC; Denslow ND; Gross M; Guiney PD; Holbech H; Karouna-Renier NK; Katsiadaki I; Krueger H; Levine SL; Maack G; Williams M; Wolf JC; Ankley GT
    Integr Environ Assess Manag; 2017 Mar; 13(2):302-316. PubMed ID: 27791330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated decision-tree testing strategies for environmental toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():29-42. PubMed ID: 19025330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissues.
    Rovida C; De Angelis I; Lorenzetti S
    ALTEX; 2013; 30(2):253-5. PubMed ID: 23665809
    [No Abstract]   [Full Text] [Related]  

  • 7. Population-relevant endpoints in the evaluation of endocrine-active substances (EAS) for ecotoxicological hazard and risk assessment.
    Marty MS; Blankinship A; Chambers J; Constantine L; Kloas W; Kumar A; Lagadic L; Meador J; Pickford D; Schwarz T; Verslycke T
    Integr Environ Assess Manag; 2017 Mar; 13(2):317-330. PubMed ID: 28052490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A testing strategy for the identification of mammalian, systemic endocrine disruptors with particular focus on steroids.
    Kolle SN; Ramirez T; Kamp HG; Buesen R; Flick B; Strauss V; van Ravenzwaay B
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):259-78. PubMed ID: 22554500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds.
    Fabian E; Gomes C; Birk B; Williford T; Hernandez TR; Haase C; Zbranek R; van Ravenzwaay B; Landsiedel R
    Arch Toxicol; 2019 Feb; 93(2):401-416. PubMed ID: 30552464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative approaches to vertebrate ecotoxicity tests in the 21st century: A review of developments over the last 2 decades and current status.
    Lillicrap A; Belanger S; Burden N; Pasquier DD; Embry MR; Halder M; Lampi MA; Lee L; Norberg-King T; Rattner BA; Schirmer K; Thomas P
    Environ Toxicol Chem; 2016 Nov; 35(11):2637-2646. PubMed ID: 27779828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic benefits of using adaptive predictive models of reproductive toxicity in the context of a tiered testing program.
    Martin MT; Knudsen TB; Judson RS; Kavlock RJ; Dix DJ
    Syst Biol Reprod Med; 2012 Feb; 58(1):3-9. PubMed ID: 22239076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():123-38. PubMed ID: 19025336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):65-80. PubMed ID: 18333715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting chemical impacts on vertebrate endocrine systems.
    Nichols JW; Breen M; Denver RJ; Distefano JJ; Edwards JS; Hoke RA; Volz DC; Zhang X
    Environ Toxicol Chem; 2011 Jan; 30(1):39-51. PubMed ID: 20963851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wind of change challenges toxicological regulators.
    Tralau T; Riebeling C; Pirow R; Oelgeschläger M; Seiler A; Liebsch M; Luch A
    Environ Health Perspect; 2012 Nov; 120(11):1489-94. PubMed ID: 22871563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.
    Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK
    Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the development the US Environmental Protection Agency's Medaka Extended One Generation Reproduction Test (MEOGRT) using data from 9 multigenerational medaka tests.
    Flynn K; Lothenbach D; Whiteman F; Hammermeister D; Touart LW; Swintek J; Tatarazako N; Onishi Y; Iguchi T; Johnson R
    Environ Toxicol Chem; 2017 Dec; 36(12):3387-3403. PubMed ID: 28857258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.